Pharmaids Pharmaceuticals Ltd

NSE: BSE: 524572

₹32.01

(-3.58%)

Mon, 30 Mar 2026, 02:19 pm

MTF 5xInvest in Pharmaids Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap1.13B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Pharmaids Pharmaceuticals Ratios

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	0	0	0	0	0	0	26.36	19.33	0	0	0	11.88	0	0	138.46	123.54	88.85	0	0	0
Price to book ratio	0	0.55	0.77	0.36	0.44	1	0.48	0.47	0.47	0.61	1.46	0.94	0.94	0.58	0.55	1.37	1.50	2.10	2.55	4.09
Price to sales ratio	14.46	3.15	4.16	2.19	1.97	2.71	0.81	0.78	0.60	0.58	1.09	1.08	2.06	8.67	0	1.35	3.27	0	7.82	12.45
Price to cash flow ratio	0	0	20	21.39	17.70	17.63	3.98	5.87	10.90	4.78	0	4.35	0	0	0	28.44	0	0	0	0
Enterprise value	0	24.97M	28.98M	18.05M	18.86M	28.74M	15.14M	13.47M	10.58M	11.14M	21.41M	6.85M	6.87M	47.48M	46.18M	113.28M	124.92M	120.67M	1.2B	2.75B
Enterprise value to EBITDA ratio	0	0	0	0	0	0	11.20	17.80	0	0	0	0	0	0	0	95.98	91.12	0	0	0
Debt to equity ratio	0	0.42	0.44	0.44	0.46	0.48	0.27	0.24	0.20	0.18	0.38	0	0	0	0	0	0	0	0.12	0.66
Return on equity %	0	0	-7.64	-4.63	-5.50	-5.17	1.80	2.50	-18.51	-3.83	-27.23	8.34	-32.75	-3.80	0.73	1.11	1.71	-48.85	-16.89	-16.43

Pharmaids Pharmaceuticals Ltd Ratios

The Pharmaids Pharmaceuticals Ltd Ratios page provides a complete fundamental analysis of Pharmaids Pharmaceuticals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Pharmaids Pharmaceuticals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Pharmaids Pharmaceuticals Ltd (NSE: , BSE: 524572) is currently trading at ₹32.01, with a market capitalization of ₹1.13B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Pharmaids Pharmaceuticals Ltd remains a key stock for fundamental analysis using Pharmaids Pharmaceuticals Ltd Ratios.

Pharmaids Pharmaceuticals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Pharmaids Pharmaceuticals Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Pharmaids Pharmaceuticals Ltd Ratios.

Historically, the Pharmaids Pharmaceuticals Ltd P/E ratio has shown strong fluctuations:

2024: 0
2023: 0
2022: 0
2021: 88.85
2020: 123.54

The decline in Pharmaids Pharmaceuticals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Pharmaids Pharmaceuticals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.09.

Historical P/B trend:

2024: 4.09
2023: 2.55
2022: 2.10
2021: 1.50

Pharmaids Pharmaceuticals Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Pharmaids Pharmaceuticals Ltd P/S ratio currently stands at 12.45, an important part of Pharmaids Pharmaceuticals Ltd Ratios for revenue valuation.

Historical P/S ratio:

2024: 12.45
2023: 7.82
2022: 0
2021: 3.27

The rising Pharmaids Pharmaceuticals Ltd P/S ratio indicates improved revenue valuation by investors.

Pharmaids Pharmaceuticals Ltd Price to Cash Flow Ratio (P/CF)

The Pharmaids Pharmaceuticals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Pharmaids Pharmaceuticals Ltd Price to Cash Flow Ratio:

2024: 0
2023: 0
2022: 0
2021: 0
2020: 28.44

The declining Pharmaids Pharmaceuticals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Pharmaids Pharmaceuticals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Pharmaids Pharmaceuticals Ltd EV currently stands at ₹2.75B, representing the total company valuation including debt.

Historical EV trend:

2024: 2.75B
2023: 1.2B
2022: 120.67M
2021: 124.92M

Pharmaids Pharmaceuticals Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Pharmaids Pharmaceuticals Ltd EV/EBITDA ratio is currently 0, a key metric in Pharmaids Pharmaceuticals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

2024: 0
2023: 0
2022: 0
2021: 91.12

Stable Pharmaids Pharmaceuticals Ltd EV/EBITDA indicates balanced valuation.

Pharmaids Pharmaceuticals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Pharmaids Pharmaceuticals Ltd D/E ratio is currently 0.66, reflecting leverage and financial stability.

Historical D/E:

2024: 0.66
2023: 0.12
2022: 0
2021: 0

Pharmaids Pharmaceuticals Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Pharmaids Pharmaceuticals Ltd ROE currently stands at -16.43%, showing profitability and capital efficiency.

Historical ROE:

2024: -16.43
2023: -16.89
2022: -48.85
2021: 1.71

Declining ROE indicates pressure on profitability.

Pharmaids Pharmaceuticals Ltd Ratios Analysis Summary

The Pharmaids Pharmaceuticals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Pharmaids Pharmaceuticals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Pharmaids Pharmaceuticals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800